Prime Capital Investment Advisors LLC Makes New $770,000 Investment in Trulieve Cannabis Corp. $TRLV

Prime Capital Investment Advisors LLC acquired a new stake in Trulieve Cannabis Corp. (NYSE:TRLV) in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm acquired 70,670 shares of the company’s stock, valued at approximately $770,000.

Wall Street Analysts Forecast Growth

Several equities research analysts recently weighed in on the company. Weiss Ratings restated a “sell (d-)” rating on shares of Trulieve Cannabis in a research note on Friday, September 11th. Wall Street Zen downgraded shares of Trulieve Cannabis from a “buy” rating to a “hold” rating in a research report on Saturday, August 8th. Finally, Cantor Fitzgerald reissued an “overweight” rating and issued a $15.00 price target on shares of Trulieve Cannabis in a research report on Friday. One analyst has rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $15.00.

Trulieve Cannabis Stock Down 4.8%

NYSE:TRLV opened at $10.40 on Friday. The company has a quick ratio of 3.98, a current ratio of 5.94 and a debt-to-equity ratio of 0.45. Trulieve Cannabis Corp. has a 52-week low of $4.62 and a 52-week high of $13.28. The stock’s 50 day moving average price is $11.17. The stock has a market cap of $2.00 billion and a P/E ratio of 94.52.

Trulieve Cannabis (NYSE:TRLV) last announced its earnings results on Friday, August 7th. The company reported $0.11 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.06 by $0.05. The business had revenue of $271.00 million for the quarter, compared to analyst estimates of $268.82 million. Trulieve Cannabis had a negative net margin of 41.55% and a negative return on equity of 4.24%. As a group, sell-side analysts anticipate that Trulieve Cannabis Corp. will post 0.31 EPS for the current fiscal year.

Trulieve Cannabis Company Profile

Trulieve Cannabis Corp. is a vertically integrated cannabis company that cultivates, processes and sells medical and adult-use cannabis products. Its offerings include flower, pre-rolls, concentrates, vaporizers, edibles, tinctures, capsules and topical products, sold through retail dispensaries and other approved channels under brands such as Trulieve, Cultivar Collection, Muse, Roll One and Alchemy.

Founded in 2015, Trulieve initially built its business around Florida’s medical cannabis market and later expanded into additional U.S.